LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
39.19
-3.50 (-8.20%)
At close: Sep 23, 2026, 4:00 PM EDT
39.19
0.00 (0.00%)
After-hours: Sep 23, 2026, 4:31 PM EDT
LB Pharmaceuticals Market Cap
LB Pharmaceuticals has a market cap or net worth of $1.26 billion as of September 23, 2026. Its market cap has increased by 251.63% in one year.
Market Cap
1.26B
Enterprise Value
941.66M
1-Year Change
251.63%
Ranking
Category
Stock Price
$39.19
ChartMarket Cap Chart
Since the IPO on September 11, 2025, LB Pharmaceuticals's market cap has increased from $301.50M to $1.26B, an increase of 319.31%. That is a compound annual growth rate of 300.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 1.26B | 124.49% |
| Dec 31, 2025 | 563.16M | 86.78% |
| Sep 11, 2025 | 301.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| First Tracks Biotherapeutics | 1.47B |
| Ascentage Pharma Group International | 1.45B |
| Avalyn Pharma | 1.44B |
| ORIC Pharmaceuticals | 1.40B |
| Alpha Tau Medical | 1.40B |
| Cullinan Therapeutics | 1.39B |
| Damora Therapeutics | 1.38B |
| Latigo Biotherapeutics | 1.38B |